NCT05617846Not yet recruiting
Application of Antiosteoporosis Therapy in Osteolysis
Efficacy and Safety of Antiosteoporosis Therapy in Patients After Bone Tumor Resection: a Multicenter, Real-world Prospective Cohort Observational Study
Source: ClinicalTrials.gov · Last updated 18 Jan 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To report the postoperative complications and limb function of patients with osteolysis after surgery for bone tumors of the extremities who received anti-osteoporosis therapy in Henan Cancer Hospital in the next 10 years.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 100 (estimated)
- First submitted
- 31 Oct 2022
- Start date
- 28 Dec 2024
- Primary completion date
- 30 Nov 2032
- Lead sponsor
- Henan Cancer Hospital
- Diseases
- Childhood cancers
- NCT number
- NCT05617846
What you commit to
- Study type: Observational
- Planned participants: 100
- From 28 Dec 2024 to the primary completion date, 30 Nov 2032
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Not applicable.
Who the study is looking for
- No age restriction, male or female.
- A subtype of bone tumor (including benign, malignant, and metastatic cancer) was confirmed in the pathology department of the research institution.
- Received excision of bone tumor in research institution.
Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Bone and Soft Tissue ,Henan Cancer Hospital Coordinator of this site? Confirm its status | Zhengzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.